Asosiy kontentga oʻtish
Maqola

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐VazImperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United KingdomMartina De MarcoImperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United KingdomChristophe StevensImperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United KingdomAsif AkramLiving Goods, Nairobi, KenyaTomáš FreibergerCentrum kardiovaskulární a transplantační chirurgieG. Kees HovinghDepartment of Vascular Medicine, Academic Medical Centre, Amsterdam, the NetherlandsJohn J.P. KasteleinDepartment of Vascular Medicine, Academic Medical Centre, Amsterdam, the NetherlandsPedro MataFundacin Hipercolesterolemia Familiar, Madrid, SpainFrederick J. RaalDivision of Endocrinology & Metabolism, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaRaúl D. SantosHeart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, BrazilHandrean SoranGerald F. WattsSchool of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, AustraliaMarianne AbifadelLaboratory of Biochemistry and Molecular Therapeutics, Faculty of Pharmacy, Pôle Technologie-Santé, Saint Joseph University, Beirut, LebanonCarlos A. Aguilar‐SalinasInstituto Nacional de Ciencias Mdicas y Nutricin, Mexico City, MexicoMutaz Al-KhnifsawiAl-Qadisiyah University, Faculty of Medicine, Department of Internal Medicine, Diwaniya City, IraqFahad AlkindiHamad Medical Corporation, Heart Hospital, Doha, QatarFahad AlnouriCardiovascular Prevention Unit, Prince Sultan Cardiac Centre Riyadh, Riyadh, Saudi ArabiaRodrigo AlonsoClnica Las Condes, Santiago de Chile, ChileKhalid Al‐RasadiClinical Centre of Cardiology, University Clinical Centre, Gdask, PolandAhmad Al‐SarrafLaboratory Department, Kuwait Cancer Control Centre, Kuwait City, KuwaitTester F. AshavaidNational HospitalChristoph J. BinderDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, AustriaMartin P. BogsrudNorwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, NorwayMafalda BourbonUnidade I&D, Grupo de Investigao Cardiovascular, Departamento de Promoo da Sade e Doenas No Transmissveis, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa, PortugalÉric BruckertDepartment of Endocrinology, Institut E3M et IHU Cardiomtabolique (ICAN), Hpital Piti Salptrire, Paris, FranceKrzysztof ChlebusFirst Department of Cardiology, Medical University of Gdansk, Gdańsk, PolandPablo CorralUniversity Medical Centre Ljubljana, University Children's Hospital, Department of Endocrinology, Diabetes and Metabolism, Ljubljana, SloveniaOlivier DescampsCentres Hospitaliers Jolimont, Haine Saint-Paul, BelgiumRonen DurstCardiology Department and Centre for Treatment and Prevention of Atherosclerosis, Hadassah Hebrew University Medical Centre, Jerusalem, IsraelМ. В. ЕжовNational Cardiology Research Centre, Ministry of Health of the Russian Federation, RussiaZlatko FrasUniversity Medical Centre Ljubljana, Division of Medicine, Preventive Cardiology Unit, Ljubljana, SloveniaJacques GenestResearch Institute of the McGill University Health Centre, Montreal, Quebec, CanadaUrh GrošeljUniversity Medical Centre Ljubljana, University Children's Hospital, Department of Endocrinology, Diabetes and Metabolism, Ljubljana, SloveniaMariko Harada‐ShibaNational Cerebral and Cardiovascular Centre Research Institute, Suita, Osaka, JapanMeral KayıkçıoğluEge University Medical School, Department of Cardiology, Izmir, TurkeyKatarina LalićClinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade, SerbiaCarolyn S.P. LamDuke-NUS Medical School, SingaporeGustavs LatkovskisResearch Institute of Cardiology and Regenerative Medicine, Faculty of Medicine, University of Latvia, Pauls Stradins Clinical University Hospital, Riga, LatviaUlrich LaufsKlinik und Poliklinikfür Kardiologie, Universitätsklinikum Leipzig, GermanyEvangelos LiberopoulosFaculty of Medicine, University of Ioannina, Ioannina, GreeceJie LinBeijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaVincent MaherAdvanced Lipid Management and Research (ALMAR) Centre, Ireland ax Hospital Militar de Caracas, Caracas, VenezuelaNelson MajanoHospital Militar de Caracas, Caracas, VenezuelaAdéle MaraisUniversity of Cape Town and National Health Laboratory Service, Cape Town, South AfricaWinfried MärzSynlab Akademie, Synlab Holding Deutschland GmbH, Mannheim und Augsburg, GermanyErkin М МirrakhimovKyrgyz State Medical Academy, Centre of Cardiology and Internal Diseases, Biskek, KyrgizstanAndré R. MiserezFaculty of Medicine, University of Basel, Basel, SwitzerlandOlena MitchenkoDyslipidemia Department, State Institution National Scientific Centre "The M.D. Strazhesko Institute of Cardiology National Academy of Medical Sciences of Ukraine", Kiev, UkraineHapizah NawawiInstitute of Pathology, Laboratory and Forensic Medicine (I-PPerForM) and Faculty of Medicine Universiti Teknologi MARA, Jalan Hospital, Sungai Buloh, Selangor, MalaysiaBørge G. NordestgaardFaculty of Health and Medical Sciences, University of Copenhagen, DenmarkGyörgy ParaghDepartment of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, HungaryŽaneta PetrulionienėClinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, Vilnius, LithuaniaBelma PojskićCantonal Hospital Zenica, Bosnia and HerzegovinaArman PostadzhiyanClinical Centre of Cardiology, University Clinical Centre, Gdask, PolandAshraf RedaEgyptian Association of Vernacular Biology and Atherosclerosis (EAVA), EgyptŽeljko ReinerDepartment of Internal Medicine, Division of Metabolic Diseases, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, CroatiaWilson E. SadohCardiology Unit, Department of Child Health, University of Benin Teaching Hospital, Benin City, Edo State, NigeriaAmirhossein SahebkarBiotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, IranAbdullah ShehabDepartment of Endocrinology, Institut E3M et IHU Cardiomtabolique (ICAN), Hpital Piti Salptrire, Paris, FranceAleksander B. ShekCAD and Atherosclerosis Laboratory, Republican Specialized Centre of Cardiology (RSCC), Ministry of Health of the Republic of Uzbekistan, Tashkent, UzbekistanMario StollTa‐Chen SuDepartments of Internal Medicine and Environmental & Occupational Medicine, Cardiovascular Centre, National Taiwan University Hospital, Taipei, TaiwanTavintharan SubramaniamClinical Research Unit, Khoo Teck Puat Hospital, SingaporeAndrey V. SusekovPhivos SymeonidesHippocrateon Private Hospital, Nicosia, CyprusMyra TilneyDepartment of Medicine, Faculty of Medicine and Surgery, University of Malta, MaltaBrian TomlinsonDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative RegionThanh‐Huong TruongVietnam National Heart Institute, Bach Mai Hospital, Hanoi, Viet NamAlexandros D. TselepisAtherothrombosis Research Centre, University of Ioannina, Ioannina, GreeceAnne Tybjærg‐HansenRigshospitaletAlejandra Vázquez-CárdenasFacultad de Medicina, Universidad Autónoma de Guadalajara, Guadalajara, MexicoMargus ViigimaaNorth Estonia Medical CentreBranislav VohnoutCoordination Centre for Familial Hyperlipoproteinemias, Slovak Medical University, Bratislava, SlovakiaElisabeth WidénInstitute for Molecular Medicine FinlandShizuya YamashitaFirst Department of Cardiology, Medical University of Gdansk, Gdask, PolandMaciej BanachDepartment of Hypertension, Medical University of Lodz, Lodz, PolandDan GaițăUniversity Medical Centre Ljubljana, Division of Medicine, Preventive Cardiology Unit, Ljubljana, SloveniaLixin JiangNational Clinical Research Centre of Cardiovascular Diseases, Fuwai Hospital, National Centre for Cardiovascular Diseases, Beijing, ChinaLennart NilssonDepartment of Medical and Health Sciences, Linköping University, Linköping, SwedenLourdes Ella G. SantosCardinal Santos Medical Centre, University of the Philippines – Philippine General Hospital (UP-PGH), PhilippinesHeribert SchunkertDeutsches Herzzentrum München, Technische Universität München, Deutsches Zentrumfür Herz- und Kreislauferkrankungen (DZHK), Munich Heart Alliance, GermanyLâle TokgözoğluDepartment of Cardiology, Hacettepe University, Ankara, TurkeyJosip CarCentre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, SingaporeAlberico L. CatapanoDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, ItalyKausik K. RayImperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom
Atherosclerosisjournal2018en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

Identifikatorlar

Iqtiboslar va manbalar